NCT02676401View on ClinicalTrials.gov

An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

August 31, 2017

Conditions
Diabetic Nephropathy
Interventions
DRUG

MT-3995 Low

DRUG

MT-3995 Middle

DRUG

MT-3995 High

Trial Locations (1)

Unknown

Touei Hospital, Hokkaido

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY